Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late Phase 2 Double-Blind Study of Enarodustat (JTZ-951) in Anemic CKD Patients Not Requiring Dialysis
jRCT2080222829Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of enarodustat in anaemia (3 arms), sponsored by Japan Tobacco. Primary endpoint: Hemoglobin increase rate dose-response. Started Apr 2015; status: completed.
02
Drugs
enarodustat
03
Conditions
anaemia
Beyond the preview
Go deeper on jRCT2080222829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222829.